logo
Plus   Neg
Share
Email

Royal Philips Q3 Comps. Up 6% - Quick Facts

Royal Philips (PHGFF.PK,PHG) said it expects third-quarter Group sales of approximately 4.7 billion euros, a 6 percent comparable sales growth. Comparable order intake growth is expected to be flat. Adjusted EBITA is anticipated to be around 583 million euros. Net income from continuing operations is projected to be approximately 210 million euros, which will include a charge of 78 million euros related to a goodwill impairment in Connected Care.

Frans van Houten, CEO of Royal Philips, said: "While I am pleased with the operational performance improvements in the Diagnosis & Treatment and Personal Health businesses, it is disappointing that margins declined in the Connected Care businesses. We will drive further strong mitigating actions to accelerate the improvement in these businesses."

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Apple Inc. (AAPL) unveiled a 16-inch MacBook Pro laptop with a larger screen and redesigned keyboard. It is the first major update since the MacBook Pro line was revamped three years ago. The company has moved from a 15-inch screen to a higher-resolution 16-inch screen. Facebook has launched its new payment platform called 'Facebook Pay' in the U.S., joining other tech giants like Google and Apple that have their own payment platforms. The new service will be available across Facebook and its associated apps - Messenger, Instagram and WhatsApp, the social media giant said in a blog post. The payment service supports most major credit and debit cards. Amneal Pharmaceuticals, LLC recalled certain lots of heartburn medication Ranitidine in the form of tablets and syrup for the potential presence of nitrosamine impurity, N-Nitrosodimethylamine, above levels established by the U.S. Food and Drug Administration or FDA. The generic and specialty pharma company is recalling 94 lots of Ranitidine tablets and Syrup.
Follow RTT
>